Go to content
- {{#headlines}}
- {{title}} {{/headlines}}
Profile
| Academic position | Full Professor |
|---|---|
| Research fields | Organic Molecular Chemistry |
| Keywords | Asymmetric Catalysis, Photocatalysis, Organic Synthesis, Small molecule drugs, Organofluorine Compounds |
| Honours and awards | 2025: Japan Society for the Promotion of Science (JSPS) Fellowship 2024: Purdue Acorn Award 2023: Distinguished Alumni Award from the University of Texas at Austin 2021: Maximizing Investigator Research Award for Established Investigator (NIGMS, 2021-2026) 2019: National Science Foundation CAREER Award (2019-2024) 2019: Young Academic Investigator (ACS-Division of Organic Chemistry) 2017: ChemComm Emerging Investigator 2016: Maximizing Investigator Research Award (NIGMS, 2016-2021) 2016: Thieme Chemistry Journal Award 2016 2015: Organic & Biomolecular Chemistry New Talent 2009: Croucher Foundation Postdoctoral Fellowship (2009-2011) 2007: Presidential Green Chemistry Challenge Award (Environmental Protection Agency, US) 2007: Wendell Gordon Fellowship (UT Austin) 2007: William S. Livingston Award for the Outstanding Graduate Student Academic Employee (UT Austin) 2004: Robert H. Hamilton/Eugene P. Schoch Fellowship (UT Austin) |
Current contact address
| Country | Germany |
|---|---|
| City | Regensburg |
| Institution | Universität Regensburg |
| Institute | Institut für Organische Chemie |
Host during sponsorship
| Prof. Dr. Oliver Reiser | Institut für Organische Chemie, Universität Regensburg, Regensburg |
|---|---|
| Prof. Dr. Armido Studer | Organisch-Chemisches Institut, Universität Münster, Münster |
| Start of initial sponsorship | 01/05/2026 |
Programme(s)
| 2025 | Friedrich Wilhelm Bessel Research Award Programme |
|---|
Nominator's project description
| Professor Ngai made groundbreaking discoveries in transition metal catalysis. His research seeks to translate advances in catalytic synthesis into biological applications, enabling the discovery and development of new therapeutics and diagnostic tools for human diseases, including cancer, neurological disorders and diabetes. In Germany, Professor Ngai will continue his research on developing new catalytic platforms that harness visible light, focusing on excited-state copper complexes as a sustainable alternative to precious-metal photocatalysts. |